Amarin Corp Plc (AMRN)

[Ray]

As we approach Q.1 2016, this company should start to see momentum heading into RI interim analysis. Volume should start to increase as many bios do heading into binary event such as adcomm or Phase III. Volume has been anemic and the share price suggests RI will not be stopped due to efficacy. There was a SA article written about a year ago talking about what would happen to PPS if we demonstrated efficacy but not strong enough to halt. As I recall, the share price would drop to roughly $1.50. I tend to believe if there's no major news by early Jan, we will drift lower. Some of you are caught up in guessing weekly scripts and the control group fall rate.

I would certainly entertain feedback on AMRN speculation that would move the needle (share price). News of additional ROW partners should move the share price over $2 at least temporarily. We're now probably in the bottom of the 7th inning w/o major catalysts or speculative insight.